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Human respiratory syncytial virus (RSV) is the leading cause of respiratory tract infections
in children globally, with nearly all children experiencing at least one infection by the age of
two. Partial sequencing of the attachment glycoprotein gene is conducted routinely for gen-
otyping, but relatively few whole genome sequences are available for RSV. The goal of our
study was to sequence the genomes of RSV strains collected from multiple countries to fur-
ther understand the global diversity of RSV at a whole-genome level.
Methods
We collected RSV samples and isolates from Mexico, Argentina, Belgium, Italy, Germany,
Australia, South Africa, and the USA from the years 1998-2010. Both Sanger and next-
generation sequencing with the Illumina and 454 platforms were used to sequence the
whole genomes of RSV A and B. Phylogenetic analyses were performed using the Bayes-
ian and maximum likelihood methods of phylogenetic inference.
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Results
We sequenced the genomes of 34 RSVA and 23 RSVB viruses. Phylogenetic analysis
showed that the RSVA genome evolves at an estimated rate of 6.72 × 10-4 substitutions/
site/year (95% HPD 5.61 × 10-4 to 7.6 × 10-4) and for RSVB the evolutionary rate was 7.69 ×
10-4 substitutions/site/year (95% HPD 6.81 × 10-4 to 8.62 × 10-4). We found multiple clades
co-circulating globally for both RSV A and B. The predominant clades were GA2 and GA5
for RSVA and BA for RSVB.
Conclusions
Our analyses showed that RSV circulates on a global scale with the same predominant
clades of viruses being found in countries around the world. However, the distribution of
clades can change rapidly as new strains emerge. We did not observe a strong spatial
structure in our trees, with the same three main clades of RSV co-circulating globally, sug-
gesting that the evolution of RSV is not strongly regionalized.
Introduction
Human respiratory syncytial virus (RSV) is the leading cause of respiratory tract illness in chil-
dren globally, with nearly all children experiencing at least one infection by the age of two [1].
RSV can also regularly infect adults and causes severe illness in the elderly [2,3]. As a member
of the Paramyxoviridae family, RSV is a non-segmented negative strand RNA virus whose ge-
nome contains ten genes that encode 11 proteins. RSV is divided into two distinct subtypes (A
and B) and each have been divided into multiple genotypes that have been found to co-circu-
late [4,5]. Most genetic studies of RSV are focused on the attachment glycoprotein (G) gene
which is the most variable and has been commonly used for genotyping [6–8]. The same geno-
types have generally been shown to circulate globally [9–12].
When we started this study in 2009, there were relatively few sequences for RSV in GenBank.
The majority were partial coding sequences, and the limited number of whole genome se-
quences were mainly from viruses collected more than 20 years prior or experimentally derived
mutants. The lack of whole-genome data made it particularly difficult to design diagnostic tests
for RSV capable of detecting the broad diversity of modern strains. To fill this void, we collected
RSV viruses fromMexico, Argentina, Belgium, Italy, Germany, Australia, South Africa, and the
USA from 1998–2010. From these isolates we sequenced the complete genomes of 57 RSV vi-
ruses (34 RSVA and 23 RSVB viruses). Since we started this study there have been parallel ef-
forts to sequence RSV genomes, so we have included these additional data in our analyses. A
phylogenetic analysis based on the whole genome, full G gene coding sequence (CDS), and the
second variable region of the G gene identified multiple clades circulating globally.
Materials and Methods
Ethics Statement
Samples from the Virology Laboratory of CEMIC, University of Adelaide, University Medical
Center Freiburg, and Onze Lieve Vrouw Ziekenhuis were collected for routine viral diagnostic
testing and de-identified prior to shipment to the Medical College of Wisconsin. Samples from
the Autonomous University of San Luis Potosí were collected with written informed consent as
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approved by the Research and Ethics Committee. Samples from the Fondazione IRCCS Policli-
nico San Matteo were collected with written informed consent as approved by the Bioethics
Committee of the Fondazione IRCCS Policlinico San Matteo. Samples from the University of
Pretoria were collected with written informed consent as approved by the Health Sciences Re-
search Ethics Committee. Samples from the Vanderbilt Vaccine Clinic were collected with
written informed consent as approved by the Committee for the Protection of Human Subjects
of the Vanderbilt University Medical Center. At Children’s Hospital of Wisconsin and Froed-
tert Hospital samples were collected with written informed consent as approved by the Chil-
dren’s Hospital of Wisconsin Human Research Review Board. For samples collected from
minors written informed consent was obtained from their parent or guardian on their behalf.
Some samples had been de-identified and where tested under a protocol approved by the Chil-
dren’s Hospital of Wisconsin Human Research Review Board.
Sample Collection and RSV Identification from Various Locations
The Autonomous University of San Luis Potosí (San Luis Potosí, Mexico). Respiratory
samples were collected as part of research projects carried out to analyze the epidemiology of
viral respiratory infections and as part of a hospital-based infection control program; the re-
search projects were approved by the corresponding Research and Ethics Committees. Samples
were obtained by nasal wash or pharyngeal swab. Viral testing was carried out directly on respi-
ratory samples. RSV was identified with a direct immunofluorescence assay.
Virology Laboratory of CEMIC (Buenos Aires, Argentina). Nasopharyngeal aspirates or
swabs were submitted for routine viral diagnostics in a transport media (Hanks plus 2% FCS,
penicillin, streptomycin, and amphotericin B). Samples were processed for antigen detection
on pelleted cells by indirect immunofluorescence with monoclonal antibodies against RSV, ad-
enovirus, influenza A and B and parainfluenza (EMDMillipore, Billerica, MA, USA). A fluo-
rescein labeled anti-mouse IgG was used (Sigma-Aldrich Corp., St. Louis, MO, USA). Readings
were performed with a C. Zeiss microscope provided with epifluorescent equipment and a
mercury lamp.
University of Adelaide, IMVS-SA Pathology (Adelaide, Australia). Respiratory secre-
tion specimens were submitted for routine viral diagnostics for seven viruses (adenovirus, in-
fluenza A & B, parainfluenza 1, 2, & 3 and respiratory syncytial virus) andMycoplasma
pneumoniae [13]. The viruses andM. pneumoniae were identified directly from the specimens
by specific antibodies using in-house developed enzyme immunoassay. Specimens were also
inoculated into 96-well microwell cell cultures for virus isolation, spun at 1000×g for 1hr at
35°C and incubated for 5–6 days at 37°C [14].
University Medical Center Freiburg (Freiburg, Germany). Nasopharyngeal swab or
bronchoalveolar lavage samples were collected as part of routine clinical testing. RSV was iden-
tified using the ID-Tag RVP test (Luminex, Austin, TX, USA). The ethics policy of the hospital
allows for left-over specimens to be used for investigational purposes as long as they are de-
identified.
Fondazione IRCCS Policlinico San Matteo (Pavia, Italy). Approval for the study was ob-
tained from the local Ethics Committee, and informed consent was obtained from patients or
their parents. Nasopharyngeal aspirates were tested by cell culture, direct fluorescent antibody
(DFA) staining, and quantified by real time RT-PCR [15].
Department of Medical Virology, University of Pretoria (Pretoria, South Africa). Na-
sopharyngeal aspirates were submitted for routine diagnosis from patients with lower respira-
tory tract infection, hospitalized in the Kalafong and Steve Biko Academic hospitals to the
Tshwane National Health Laboratory Service laboratory, Department Medical Virology
Sequencing and Analysis of Global RSV A and B Genomes
PLOSONE | DOI:10.1371/journal.pone.0120098 March 20, 2015 3 / 22
University of Pretoria by direct immunofluorescent assay followed by confirmation by RT-
PCR, as described previously [11]. Viruses were subsequently amplified in tissue culture for the
purpose of this study. Characterization of strains by sequencing was approved and monitored
by the human ethics committee, University of Pretoria (25/2006).
Laboratory Microbiology, Onze Lieve Vrouw Ziekenhuis (Aalst, Belgium). Samples
were collected as nasopharyngeal aspirates as part of routine clinical testing. RSV was detected
using real-time RT-PCR [16]. The ethics policy of the hospital allows for left-over specimens to
be used for investigational purposes as long as they are de-identified.
Vanderbilt Vaccine Clinic (Nashville, TN, USA). Virus sequences were derived from
specimens collected prospectively over a 20-year period from 1982–2001 in the Vanderbilt
Vaccine Clinic, as previously described [17]. Nasal wash specimens were collected from chil-
dren<5 years of age with acute upper or lower respiratory illness. Nasal washes were tested by
cell culture, DFA staining, and quantified by real-time RT-PCR.
The Midwest Respiratory Virus Program, Children’s Hospital of Wisconsin, and Dyna-
care Laboratories (Milwaukee, WI, USA). Nasopharyngeal swab samples were collected
with informed consent under an IRB protocol or through routine clinical diagnosis and de-
identified. RSV was identified by an in-house real-time RT-PCR.
Samples from the above locations where all frozen at -20°C to -85°C and held frozen until
shipped to the Midwest Respiratory Virus Program for further analysis. Some of the viruses were
amplified in tissue culture by inoculation in Hep-2 cells for 3–5 days prior to use in this study.
Sanger Sequencing of RSV Genomes
Two sets of 96 pairs of degenerate RSV-specific primers tiled across the entire viral genome
were designed from the consensus sequences of either three RSV-A or three RSV-B reference
genomes (RSV-A accessions: RSVA/WI/629–4071/98 (JF920065), RSVA/WI/629–9/06–07
(JF920070) and RSVA/WI/629-Q0282/10 (JF920054); RSV-B accessions: RSVB/WV/14647/85
ATCC-VR1400 (unpublished), RSVB/WI/629–5B/06–07 (JN032115) and RSVB/WI/629-
Q0306/10 (JN032121)) using a PCR primer design pipeline developed at the J. Craig Venter In-
stitute (JCVI) (S1 Text and S2 Text)[18]. The primer configuration was such that produced
tiled short-amplicons with an average length of 650 bp, 150 bp overlap, and with at least two-
fold amplicon coverage at every base. Each primer contains a M13 sequence tag at the 5’ end
used for Sanger sequencing.
Viral RNA was extracted from 100–200 μl of the samples using the ZR-96 Quick RNA(TM)
kit (Zymo Research Corp., Irvine, CA, USA), following manufacturers recommendations or
from 100–400 μl of the samples using the NucliSENS easyMag (bioMerieux, Inc., Durham,
NC, USA) with elution in 25 μl. RNA from each sample was subjected to RT-PCR using a QIA-
GEN One-step kit (QIAGEN, Hilden, Germany) with four pairs of primers specific to either
RSVA or B to determine the RSV type. Then, RT-PCR was performed to produce 650 bp
amplicons from each of the 96 primer pairs from one of the two RSV-specific sets, A or B. Ex-
cess primers and dNTPs were removed by treatment with Exonuclease I (New England Biolabs,
Ipswich, MA, USA) and shrimp alkaline phosphatase (Affymetrix, Santa Clara, CA, USA):
37°C for 60 min, followed by incubation at 72°C for 15 min, and then subjected to Sanger se-
quencing with M13 primers.
Sequencing reads were trimmed to eliminate amplicon primer and low-quality sequences,
and assembled with Minimus, a program from the AMOS project [19]. Draft assemblies were
evaluated with an in-house software, CLOE (Closure Editor, http://cloe.sourceforge.net), and
targeted PCR-based sequencing reactions were conducted to close gaps and improve sequence
coverage. Curated assemblies were validated and annotated with the viral annotation software
Sequencing and Analysis of Global RSV A and B Genomes
PLOSONE | DOI:10.1371/journal.pone.0120098 March 20, 2015 4 / 22
VIGOR [20] and predicted genes were subjected to manual inspection and quality control be-
fore submission to GenBank.
Sequencing of RSV Genomes by NextGen Technology
RSV isolates that could not be completely sequenced by Sanger were processed using JCVI’s
Next Generation Sequencing Pipeline. Extracted genomic RNA was reverse transcribed with
RSV-specific degenerate primers scattered along the RSV genome at intervals of approximately
4 kb using SuperScript III (Thermo Fisher Scientific, Waltham, MA, USA) (S1 Table). The re-
sulting cDNA was used to generate a set of ~4 kb PCR-amplicons encompassing the entire
RSV genome. PCR reactions were carried out with Accuprime (Thermo Fisher Scientific) using
pairs of degenerate primers selected from the two pools of 96 primer pairs used for the Sanger
sequencing pipeline. Each amplicon was gel purified and then simultaneously amplified and
bar-coded using a modified sequence-independent single-primer amplification (SISPA) ap-
proach [21]. A pool of these and other viral samples were used to construct Illumina and 454
paired-end libraries and sequenced on their respective platforms. After sequencing, reads from
each sample were sorted by barcode and trimmed to eliminate low quality regions as well as
SISPA hexamer primer and barcode sequences. The Illumina and 454 reads were then assem-
bled de novo using the clc_novo_assemble program (QIAGEN). The resulting contigs were
then used to pick the best reference RSV genome, which was then used for a reference-based
assembly using the clc_ref_assemble_long program. The assembled sequences were annotated
using VIGOR as described above.
Recombinant Analysis
All RSV genome sequences available in GenBank as of 9/24/2013 were downloaded and com-
bined with the genomes produced in this study. Genomes from mutant RSV strains were ex-
cluded (AF013255, AF035006, U39661, U50362, U50363, and U63644). The genomes were
separated by RSV subtype and aligned using MAFFT [22]. Each alignment was checked for re-
combination using the RDP, GENECONV, Chimaera, MaxChi, BootScan, SiScan, and 3Seq al-
gorithms in RDP4 [23]. In order for a recombination event to be considered real it had to be
detected by at least three of the algorithms. For the RSVA alignment there was a group of 14 ge-
nome sequences (GU591758—GU591771) from a single study that produced an excessive
number of recombination events, as observed in a previous study [24]. These genomes were re-
moved and the analyses were repeated. Any recombination events found were considered to
most likely be sequencing errors and not true recombination. Therefore, the minor sequence in
each recombinant was removed from these sequences and excluded from subsequent analyses.
Positive Selection
All sequences available for each RSV gene were downloaded from GenBank and separated by
RSV type. Sequences less than 200 base pairs or from a patent were excluded. Sequences were
aligned using MAFFT and were trimmed to only the coding sequence. Coding sequences less
than 50 base pairs were removed and for some genes longer sequences were removed because
of non-overlapping partial sequences not aligning properly (<600bp for RSVA N gene,
<500bp for RSVA F gene, and<650bp for RSVA and B G gene). Positive selection was deter-
mined for each alignment using the SLAC, FEL, and FUBAR algorithms available on the Data-
monkey webserver [25–28]. Sites were only considered positive if they met the cutoff criteria
for at least two of the algorithms, that is a p-value of less than 0.05 for SLAC and FEL and pos-
terior probability of greater than 0.95 for FUBAR.
Sequencing and Analysis of Global RSV A and B Genomes
PLOSONE | DOI:10.1371/journal.pone.0120098 March 20, 2015 5 / 22
Phylogenetic Analyses
The set of whole genome sequence alignments resulting from the recombination analysis
(RSVA: 105 sequences, RSVB: 70 sequences), alignments of the full G gene CDS that have col-
lection dates available in GenBank (RSVA: 181 sequences, RSVB: 128 sequences), and align-
ments of the G gene second hypervariable region for both RSVA and RSVB (RSVA: 1117
sequences, RSVB: 750 sequences) were used for the phylogenetic analyses with the Bayesian
method of phylogenetic inference in BEAST v1.8.0 and the maximum likelihood method in
MEGA 6.05 [29,30].
For the partial CDS alignments of the second hypervariable region in the G gene, there were
many duplicate sequences. Duplicate sequences were removed with only one instance of each
sequence left for each country for each year. Alignments were imported into BEAUti v1.8.0,
which was used to generate xml files for use in BEAST v1.8.0. Collections dates were used to as-
sign tip dates. A general-time reversible (GTR) model of nucleotide substitution was used with
a gamma-distributed (Γ) rate variation among sites, with a proportion of invariant sites. An
uncorrelated lognormal (UCLN) relaxed molecular clock was used with a flexible Bayesian sky-
line tree prior.
For the full CDS analysis the same model was used without a proportion of invariant sites.
BEAST was used to perform a Bayesian MCMC analysis for the genome and full CDS align-
ments. The MCMC chain length was 250 million for the RSVA genomes, 50 million for the
RSVB genomes, 150 million for the RSVA full G CDS, and three runs of 150 million for RSVB
full G CDS that were combined using LogCombiner v1.8.0. The Markov chain was sampled
10,000 times for each run. BEAST results were analyzed using Tracer v1.6 and summary trees
were produced using TreeAnnotator v1.8.0. Maximum likelihood trees were inferred for the
genome, full CDS, and partial CDS alignments with MEGA 6.05 using the GTR model with
gamma-distributed rate variant among sites. Trees were visualized and annotated in FigTree
v1.4.0.
To compare the evolutionary rates between genes we extracted the complete CDS sequences
for each of the 12 genes from the whole genome data sets. Alignments for each CDS were made
using MAFFT. Bayesian MCMC analysis was performed with BEAST as described above for
the full G CDS. A chain length of 50 million was used for each CDS sampling a total of 10,000
times. Results were analyzed using Tracer v1.6.
Results and Discussion
Of the 100 RSV samples or isolates we attempted to sequence we were able to sequence ge-
nomes from 57, resulting in 34 RSVA and 23 RSVB genomes. Of these, 11 genomes were not
completely closed and contained at least one gap. These sequences could not be closed due to
insufficient sample for additional sequencing. We suspect that the samples that could not be
completely sequenced had insufficient viral nucleic acids due to low viral load or possible sam-
ple degradation. It is unlikely that we were not able to sequence these viruses due to genetic var-
iability because the number of primers used should have at least obtained partial genome
sequences if there was sufficient nucleic acid. We did not sequence the 5’ and 3’ termini of the
genomes, so the genomes contain incomplete 5’ and 3’ non-coding regions. Since many of
these sequences (41/57) were derived directly from patient specimens they will not contain mu-
tations that can be selected for during growth in tissue culture. For those that had been grown
in tissue culture we sequenced the lowest passage available (three passages or less) for sequenc-
ing to minimize the number of culture-derived mutations. Information on the sequenced virus-
es can be found in Table 1 and all sequences can be retrieved from GenBank using the
bioproject id PRJNA73049.
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Table 1. Information on the RSV Strains Sequenced.
Accession Number Strain Name Base Pairs Gaps (bp)
KF826827 RSVA/Homo sapiens/ARG/159/2004 15209 -
KF826828 RSVA/Homo sapiens/ARG/162/2004 15191 -
KF530260 RSVA/Homo sapiens/ARG/170/2005a 14980 -
KF826838 RSVA/Homo sapiens/ARG/177/2006 15189 -
KF826841 RSVA/Homo sapiens/ARG/190/2007 15194 -
KF826846 RSVA/Homo sapiens/ARG/202/2008 15142 -
KF826847 RSVA/Homo sapiens/AUS/248/2007c 15179 -
KF826848 RSVA/Homo sapiens/AUS/249/2007c 15190 -
KF530261 RSVA/Homo sapiens/DEU/106/2008a 15100 -
KF826830 RSVA/Homo sapiens/DEU/107/2009 15186 -
KF826831 RSVA/Homo sapiens/DEU/108/2009 15195 -
KF826854 RSVA/Homo sapiens/ITA/119/2009 15192 -
KF826832 RSVA/Homo sapiens/ITA/120/2009 15176 -
KF826833 RSVA/Homo sapiens/ITA/121/2009 15129 -
KF826855 RSVA/Homo sapiens/ITA/123/2009 15163 -
KF826856 RSVA/Homo sapiens/ITA/125/2009 15188 -
KF826826 RSVA/Homo sapiens/MEX/23/2004 15197 -
KF826816 RSVA/Homo sapiens/MEX/25/2005 14948 1215
KF826836 RSVA/Homo sapiens/MEX/26/2006 15165 -
KF826837 RSVA/Homo sapiens/MEX/27/2006 15194 -
KF826840 RSVA/Homo sapiens/MEX/29/2007 15106 -
KF826817 RSVA/Homo sapiens/MEX/43/2009 14744 117
KF530268 RSVA/Homo sapiens/MEX/59/2007a 15128 -
KF826852 RSVA/Homo sapiens/USA/629–1/2007c 15167 -
KF826850 RSVA/Homo sapiens/USA/629–11–1/2008c 15193 -
KF530263 RSVA/Homo sapiens/USA/629–4/2007a, c 15118 1279
KF826823 RSVA/Homo sapiens/USA/629–4360/1998 15197 -
KF826824 RSVA/Homo sapiens/USA/629–4392/1998 15200 -
KF826821 RSVA/Homo sapiens/USA/629–8–2/2007c 15177 -
KF530269 RSVA/Hep2_lab/USA/629-Q0030_RSV60/2009a, c 15049 -
KF826849 RSVA/Hep2_lab/USA/629-Q0115_RSV89/2010c 15182 -
KF530267 RSVA/Homo sapiens/ZAF/323/2007a, b, c 15078 1518, 530, 1797, 130, 1078
KF530258 RSVA/Homo sapiens/ZAF/324/2007a, b, c 15123 592
KF530264 RSVA/Homo sapiens/ZAF/332/2008a, b, c 15039 1002, 670, 290, 174
KF826839 RSVB/Homo sapiens/ARG/187/2006 15278 -
KF826842 RSVB/Homo sapiens/ARG/195/2007 15269 -
KF826845 RSVB/Homo sapiens/ARG/201/2008 15147 -
KF530265 RSVB/Homo sapiens/DEU/111/2009a 14673 258, 670
KF826853 RSVB/Homo sapiens/DEU/114/2008 15183 -
KF530266 RSVB/Homo sapiens/DEU/115/2008a 15064 -
KF826834 RSVB/Hep2_lab/ITA/126_RSV78/2009c 15218 -
KF826835 RSVB/Hep2_lab/ITA/127_RSV79/2009c 15238 -
KF530262 RSVB/Homo sapiens/ITA/128/2009a 15045 -
KF826857 RSVB/Homo sapiens/ITA/129/2009 15278 -
KF826858 RSVB/Homo sapiens/ITA/130/2009 15233 -
KF826859 RSVB/Homo sapiens/ITA/131/2009 15263 -
(Continued)
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Recombination
We identified eight recombination events in six RSVA genomes and two events in two RSVB
genomes. Five of the RSVA genomes (JF920059, JF920061, JF920064, JF920067, and JF920068)
and one RSVB genome (JN032121) were from a previous study from our group [31], and were
identified as potential recombinants in a previous study [24]. Upon reexamining the sequenc-
ing reads we found that the reads contributing to the minor components for these genomes ap-
peared to be from a different RSV strain due to mismatches in overlapping reads near the
predicted recombination breakpoints. In one genome (JF920068) we found additional reads in
locations not detected by the recombination analysis that appeared to be from a different
strain. These reads were removed and the genomes were reassembled. Since we suspected that
all predicted recombination events were sequencing errors the predicted recombinant regions
from the remaining two genomes (JX015495 and JX576753) were also removed. These results
highlight the importance of running a recombination analysis when performing genome se-
quencing even when one does not expect true recombination events.
Entropy Plots of the RSVA and B Protein Sequences
From the whole genome alignments the CDS sequences for each RSV gene were concatenated
into a single sequence and then translated into predicted protein sequences. The entropy values
for each amino acid position were calculated using the Entropy (H(x)) plot function in BioEdit
7.0 (Fig. 1). From these plots it is clear that the G protein is the most variable in both RSVA
and B. The high variability of the G gene/protein makes it a good target for evolutionary analy-
ses, which has been the primary goal of most RSV sequencing studies. Therefore, there is a
large amount of sequence data for this gene. For the remaining genes/proteins there is signifi-
cantly less sequence data available. These more conserved regions of the genome are critical for
the development of robust diagnostics that continue to detect currently circulating strains.
Table 1. (Continued)
Accession Number Strain Name Base Pairs Gaps (bp)
KF826818 RSVB/Homo sapiens/ITA/132/2009 14730 207, 1197, 1383, 1456, 687
KF826819 RSVB/Homo sapiens/ITA/133/2009 15200 926, 737, 388
KF826820 RSVB/Homo sapiens/ITA/134/2009 15181 54
KF826860 RSVB/Homo sapiens/ITA/135/2009 15249 -
KF826825 RSVB/Homo sapiens/MEX/20/2004 15259 -
KF826829 RSVB/Homo sapiens/MEX/24/2005 15215 -
KF826843 RSVB/Homo sapiens/MEX/51/2008 15280 -
KF826844 RSVB/Homo sapiens/MEX/62/2008 15218 -
KF826851 RSVB/Homo sapiens/USA/629–24/2007c 15279 -
KF826822 RSVB/Homo sapiens/USA/629–5/2007c 15269 -
KF530259 RSVB/Homo sapiens/ZAF/319/2006a, b, c 15157 308
a These sequences were sequenced by Next-Gen sequencing.
b Partial G CDS sequences have previously been published for these samples with different strain names. Accession numbers for these sequences are
HQ711732, HQ711709, HQ711688, and HQ711801 [11].
c These sequences were produced from viruses isolated in tissue culture.
doi:10.1371/journal.pone.0120098.t001
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Positively Selected Sites
We used the SLAC, FEL, and FUBAR algorithms on the Datamonkey webserver to identify po-
tential positively selected sites for each of the coding regions in RSV [27,28]. These programs
take alignments of coding sequences and use algorithms to predict if codon sites are under dif-
ferent types of selection. In general, positions under positive selection show a shift over time
from one amino acid to another presumably due to a fitness benefit. Positions under negative
selection tend to rapidly remove amino acid variants because they may be deleterious. There
were multiple positively selected sites predicted in the G and F coding regions (Table 2). These
results are not surprising considering both of these genes produce surface glycoproteins that
likely face selective pressure from the host immune system. The predicted positively selected
sites in the fusion protein were located in the N-terminal signal peptide and the C-terminal
heptad repeat. Two additional sites (553 and 573) had initially been predicted in the RSVB F
gene cytoplasmic tail region, but upon close inspection they were found to be artifacts from
primer sequences used in previous studies [32,33]. In the attachment glycoprotein, predicted
Fig 1. Protein Entropy Plots. This is an entropy plot of the concatenated predicted protein sequences of all of the viruses sequenced in this study. Entropy
values were calculated using BioEdit 7.0 and the plot was generated using Microsoft Excel. Black bars are for RSVA sequences and red bars are for RSVB
sequences. The higher the bar is the greater the variation at that position in the protein sequence. Across the top of the plot are listed the abbreviated protein
sequence names in the order in which the CDS sequences for the proteins appear in the genome.
doi:10.1371/journal.pone.0120098.g001
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positively selected sites were located in the N-terminal cytoplasmic domain and the mucin-like
regions. It is unclear what would be driving positive selection in the few sites that are located
on the cytoplasmic regions of these proteins. None of the other RSV coding regions had sites
that met the criteria of having two of the three algorithms predicting positive selection with the
cutoffs used in this study. Since the criteria we used were fairly conservative our results do not
eliminate the possibility that there are sites under positive selection in these coding regions.
Since these algorithms were designed for sequences from divergent populations [34], Kryaz-
himskiy and Plotkin 2008 recommend that caution be taken when interpreting results from
using these algorithms with closely related sequences belonging to the same species. Generally
these algorithms use different methods to estimate the ratio of nonsynonymous changes per
nonsynonymous site (dN) to synonymous changes per synonymous site (dS). Sites with a dN/
dS ratio> 1 are considered to be under positive selection and those< 1 under negative selec-
tion. They showed that these assumptions may not always hold true with sequences from the
same population/species and sites under positive selection may be underestimated. Therefore,
it is likely that there are additional sites under positive selection that were not identified in this
study and other similar studies. Despite these limitations, other studies have also tried to iden-
tify positively selected sites in RSV.
We reviewed seven previously published studies to identify which sites have previously been
predicted to be under positive selection [24,33,35–39]. Most of these studies focused on the G
CDS, and the majority of the positively selected sites identified in this study were also identified
in one or more of the previous studies (8/10 for RSVA and 2/4 for RSVB). Across all studies
most of the sites predicted to be under positive selection were identified in only one study (60%
for RSVA and 74% for RSVB). Differences between studies can be attributed to differences in
Table 2. Sites under positive selection in RSVA and RSVB.
Type Gene Site SLAC FEL FUBAR Reference Positiona
dN-dS p-value dN-dS p-value dN-dS Post. Pr.
RSVA G 4 3.237 0.042 1.091 0.002 0.779 0.994 4
124 0.752 0.019 0.433 0.043 0.176 0.877 124
161 0.338 0.233 0.346 0.009 0.202 0.957 161
162 0.474 0.129 0.35 0.006 0.212 0.969 162
247 1.333 0.002 1.162 0.005 0.847 0.998 244
258 0.405 0.175 0.453 0.003 0.239 0.977 255
301 1.686 0.001 0.807 0.062 0.697 0.98 274
313 1.879 <0.001 0.776 0.002 0.637 0.994 286
317 2.885 0.003 0.834 0.017 0.716 0.989 290
324 2.009 0.15 1.751 0.004 2.034 0.998 297
F 19 5.37 0.083 1.931 0.029 1.025 0.964 19
518 6.54 0.026 0.787 0.008 0.324 0.956 518
RSVB G 219 4.19 <0.001 1.318 0.001 0.81 1 219
286 1.288 0.005 0.498 0.005 0.248 0.961 261
292 1.571 0.011 1.043 0.003 0.806 0.996 267
305 0.894 0.027 0.617 0.035 0.207 0.874 280
a Position in reference sequence. Accession M74568 is the reference for RSVA and AF013254 is the reference for RSVB. Sites in bold were also
predicted to be under positive selection in previous publications.
doi:10.1371/journal.pone.0120098.t002
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data sets, prediction algorithms, and cutoff criteria used. However, like the previous studies
most of the positively selected sites were identified in the highly variable mucin-like regions of
the G gene (Fig. 2). It has previously been demonstrated that both humans and rabbits produce
antibodies to these highly variable regions [40,41]. One of these studies used linear peptides
representing natural amino acid variations in the carboxy-terminal mucin-like region of the G
protein to demonstrate that human serum can contain antibodies to these regions of the pro-
tein and that even a single mutation can eliminate reactivity [41]. Additionally, reactivity of the
serum with the peptides was dependent on the genotype of the RSV virus that infected the indi-
vidual, and a mutation in one of the predicted positively selected sites (position 244 in
M74568) was found to produce an antibody escape mutant [41]. Taken together these results
support the concept that immunologic pressure is driving selection of mutations in these re-
gions and that mutations in these regions play a role in the ability of RSV to re-infect individu-
als throughout their lives.
Gene Start (GS), Gene End (GE), and Stop Codon Sequences
Each gene in RSV has a specific nine nucleotide “gene start” sequence (3’-CCCCGUUUA-5’)
that directs transcription initiation that is almost completely conserved in all genes in both
RSVA and RSVB, with only the polymerase gene (3’-CCCUGUUUU-5’) in both RSVA and
RSVB and the small hydrophobic gene (3’-CCCCAUUUA-5’) in RSVB typically having a dif-
ferent sequence. In one of our RSVB genome sequences (KF826829) we found a mutation in
the GS sequence of the SH gene resulting in 3’-CCCUAUUUA-5’ as the GS. It is unknown how
this mutation affects the viability of the virus. We found two other published RSVB sequences
(JX576736, JX576757) that had a C->Umutation in the same position of the GS sequences in
the M and F genes. Interestingly, this mutation actually matches the base at this position of the
L gene GS. This suggests that this specific mutation may be tolerated better by the transcrip-
tional machinery than other mutations in the GS sequences. To support this suggestion, a mu-
tagenesis study of the GS showed that this mutation had no negative impact on expression
levels [42]. The only other published sequences with mutations in a GS were a temperature sen-
sitive mutant of the RSV A2 strain (U63644) with an A->Gmutation at the last position of the
Fig 2. G Protein Entropy Plot and Positive Selected Sites. This is an entropy plot of the G protein sequences with positively selected sites also shown.
Entropy values were calculated using BioEdit 7.0 from the alignments used for the positive selection analysis and the plot was generated using Microsoft
Excel. Black bars are for RSVA sequences and red bars are for RSVB sequences. Sites predicted to be under positive selection in this study are shown with
black diamonds for RSVA and red diamonds for RSVB. Near the top are shown sites predicted to be under positive selection or diversifying selection from
previously published studies with black pluses for RSVA and red pluses for RSVB.
doi:10.1371/journal.pone.0120098.g002
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M2 gene GS, which was shown to be the cause of temperature sensitivity [43], and a sequence
from China with two mutations in the GS of the F gene (AY198177), which appears to have
been introduced by the amplification primers [44].
Each gene in RSV also ends with a less conserved sequence that directs transcription termi-
nation and polyadenylation that follows the motif (3’-UCAAUN1–4U4–8–5’) (Table 3). Unlike
the GS, these GE sequences are usually different for each gene, different between RSVA and
RSVB, and exhibit more strain-to-strain variation. The first five bases are conserved in most of
the GE sequences, however, some variation is observed in positions three and four. In our pre-
vious genome sequencing study we identified previously unseen variations of the GE sequences
[31]. Again in this study we found additional variant GE sequences highlighting the relative
flexibility of these sequences, which have been shown to affect the efficiency of transcription
termination which in turn affects the expression levels of downstream gene sequences [45].
Most of the variations are the result of differences in the length of the poly U tract.
Stop codon locations are generally well conserved in both location and sequence for most of
the genes in RSV. The gene with the most variable stop codons is the G gene for which varia-
tion in stop codons is common resulting in proteins of varying lengths [46]. The G gene stop
codon positions of sequences produced in this study matched the positions of those in previ-
ously published sequences. These positions were codons 298 and 299 in RSVA and 289, 292,
and 296 in RSVB using accessions M74568 and AF013254 as reference sequences. In RSVA
both stop codons are utilized with about equal frequency, while in RSVB the stop codon at po-
sition 289 is utilized most frequently in the BA clade which represents the majority of recent
isolates. In one of our RSVB sequences (KF826839) we identified a premature stop codon in
the SH gene resulting in a reduction in the expected protein size from 65 aa to 56 aa. We were
able to grow this virus in culture and we confirmed by sequencing the SH gene that the isolate
also contained the mutation. The SH protein is a viroporin that has been shown to form a pen-
tameric ring in the cell membrane that functions as a cation channel [47]. The missing 9 aa
would be part of an extended loop structure of the extracellular C-terminal domain. It is not
known if these amino acids are important for protein function.
Evolutionary Rates
The evolutionary rates of the whole genome sequences were 6.72 × 10-4 substitutions/site/year
[95% HPD 5.61 × 10-4 to 7.91 × 10-4] for RSVA and 7.69 × 10-4 substitutions/site/year [95%
HPD 6.81 × 10-4 to 8.62 × 10-4] for RSVB. The evolutionary rates based on the G CDS were
1.86 × 10-3 substitutions/site/year [95% HPD 1.64 × 10-3 to 2.08 × 10-3] for RSVA and 2.43 ×
10-3 substitutions/site/year [95% HPD 2.05 × 10-3 to 2.84 × 10-3] for RSVB. Evolutionary rates
varied among individual genes, but all remained within the range of 4.22 × 10-4–3.73 × 10-3
substitutions/site/year (Fig. 3), similar to what has been observed previously [38].
Phylogenetic Trees
We inferred maximum likelihood (ML) and maximum clade credibility (MCC) trees for the
whole genome and full G gene CDSs and only ML trees for the partial G gene CDSs. For
RSVA, the partial G gene CDS covered nucleotides 677–891 (216 nucleotides) for sequence
JN257702 and for RSVB, it covered nucleotides 640–853 (214 nucleotides) for sequence
AY353550. The size of the CDS fragment varied due to various insertions. This region was re-
ported most frequently in previous RSV phylogenetic studies and includes the 72 nucleotide in-
sertion found in the recent RSVA ON1 genotype and 60 nucleotide insertion found in the
RSVB BA genotype. We found that the trees produced by both methods for the whole genome
and full G gene CDS sequences were similar, and that there was good agreement between the
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whole genome and full G gene CDS trees. However, there were noticeable topological differ-
ences in the partial G gene CDS trees relative to the whole genome and full G gene CDS trees.
These rearrangements were most evident in RSVB, for which sequences belonging to SAB3 ge-
notype that lack the 60 nucleotide insertion were found to cluster within the BA genotype only
in the partial CDS tree. These results suggest that both the whole genome and full G gene CDS
are suitable for evolutionary analyses, but the partial G CDS alone may produce
misleading results.
RSVA Phylogenetic Analysis
The MCC tree inferred for the RSVA genome (Fig. 4) includes viruses that have previously
been characterized as belonging to one of the defined genotypes: GA1, GA2, GA5, GA7, and
Table 3. Gene End Sequences of RSVA and RSVB.
Gene RSVA RSVB
Sequence 3’!5’a Occurrencesb Sequence 3’!5’ Occurrences
NS1 UCAAUUAUAUUUU 34 UCAAUUAUAUUUU 23
NS2 UCAUU-AAAUUUU 17 UCAUU-A-AUUUUU 23
UCAAU-AAAUUUU 16
N UCAAUU—AUUUUUU 27 UCAAUU—GUUUUUU 22
UCAAUU—AUUUUUUU 1 UCAAUU—GUUUUU 1
UCAAUU—AUUUUU 3
UCAAUU—GUUUUU 2
P UCAAU—-GUUUUUUU 27 UCAUU—-GUUUUUUU 22




M UCAAUU—AUUUUUU 12 UCCAUUU-AUUUU 22
UCAAUU—AUUUUU 19 UCUAUUU-AUUUU 1
UCAAUU—AUUUUUUU 1
SH UCAAUU-AAUUUUU 26 UCAAU-AAAUUUUU 21
UCAAUU-AAUUUUUU 6 UCAAU-AAAUUUU 2
G UCAGU—AAUUUUU 29 UCAAU-AAAUUUUU 20
UCAGU—AAUUUUUU 2 UCAAU-AAGUUUUU 3
UCAAU—AAUUUUU 2
F UCAAU-AUAUUUU 29 UCAAU-GUAUUUUU 21




M2 UCAAU-AAAUUUU 30 UCAAU-AGAUUUU 20
L UCAAU-AAAUUUU 31 UCAAU—AAUUUUUU 21
UCAAU—AAUUUUU 1
UCAGU—AAUUUUUU 1
a Underlined sequences were identiﬁed previously. Dashes were added so the U-tracts line up.
b These numbers only include sequences from this study.
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ON1. The full CDS tree (S1 Fig.) also included viruses from genotypes NA1 and CB-A, while
the partial CDS tree (S2 Fig.) includes viruses from NA2 and a single virus from GA3 and
SAA1. We found that the majority of sequences in our data set that were collected globally over
the past 10 years belong to one of two clades of RSVA. The larger of these clades encompasses
the GA2, NA1, NA2, CB-A, and ON1 genotypes, with the oldest virus dating back to 1994. Dif-
ferent studies have used different reference sequences for defining genotypes, making it diffi-
cult at times to distinguish between the genotypes. Therefore, we found genotypes not to be
particularly useful to characterize viral diversity in our study, and instead will refer to this large
clade simply as the GA2 clade based on the oldest genotype found within it. The ON1 genotype
contains a 72 nucleotide insertion in the second variable region of the G gene and includes se-
quences from 2012–2013 from Canada, Italy, Germany, China, Japan, South Korea, South Af-
rica, Croatia and India [6,9]. The RSVB BA genotype also has a large insertion in the same
region (60 nt) that emerged in the late 1990s and then rapidly spread globally. It will be inter-
esting to see if the ON1 genotype becomes the predominant RSVA genotype as the BA geno-
type did for RSVB.
Fig 3. CDS Evolutionary Rates. This plot shows the estimated evolutionary rates for each CDS in RSVA and RSVB. Error bars represent the 95% HPD
values. Rates were determined using BEAST v1.8.0 with the GTRmodel of nucleotide substitution, a gamma-distributed rate variation among sites, an
uncorrelated lognormal relaxed molecular clock, and a flexible Bayesian skyline tree prior. Each CDS was ran with a chain length of 50 million and sampled
10,000 times.
doi:10.1371/journal.pone.0120098.g003
Sequencing and Analysis of Global RSV A and B Genomes
PLOSONE | DOI:10.1371/journal.pone.0120098 March 20, 2015 14 / 22
Fig 4. Tree of RSVAGenome Sequences. This is a maximum clade credibility tree of RSVA genome
sequences generated in this study and retrieved from GenBank. Tip times correspond to date of collection
with the scale axis across the bottom showing the years. Tip labels show the accession number, country of
isolation, and collection date. The labels are color coded with black for sequences from this study (FTS), grey
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The second predominant clade contains sequences from the GA5 genotype, with the oldest
one from 1993. Of the 34 RSVA genomes sequenced in this study, 16 belonged to the GA2
clade and 18 belonged to the GA5 clade. The other two clades represent the GA1 and GA7 ge-
notypes. The GA1 clade contains the oldest identified RSVA viruses (1956–1967), two viruses
from our previous study (JF920069 and JF920070, not shown due to potential contamination),
and a group of viruses from Iran from 2008–2009 (only in the partial CDS tree). One of the
Iran viruses (GU339399) is a 100% match to the A2 strain from 1961 (M74568) and the re-
maining strains are much less divergent than one would expect given the time frame [48,49].
for sequences with an undetermined genotype (UND), and the remaining colors corresponding to previous
published genotypes as show in the key in the upper left corner. Brackets highlight the major clades.
Bayesian posterior probabilities are shown for key nodes.
doi:10.1371/journal.pone.0120098.g004
Fig 5. Tree of RSVBGenome Sequences. This is a maximum clade credibility tree of RSVB genome sequences generated in this study and retrieved from
GenBank. Tip times correspond to date of collection with the scale axis across the bottom showing the years. Tip labels show the accession number, country
of isolation, and collection date. The labels are color coded with black for sequences from this study (FTS), grey for sequences with an undetermined
genotype (UND), and the remaining colors corresponding to previous published genotypes as show in the key in the upper left corner. Brackets highlight the
major clades. Bayesian posterior probabilities are shown for key nodes.
doi:10.1371/journal.pone.0120098.g005
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Therefore, we suspect that this could be a re-introduction of a laboratory strain into the popu-
lation and is now circulating in Iran. Since we retrieved the sequences used in this study, anoth-
er study has been published showing additional viruses from this clade isolated in 2012 and
2013 in Iran, providing further evidence that the this virus is indeed currently circulating and
not simply a lab/sequencing error [50]. For the GA7 clade only one virus is from after 2002
(JX256946) and is a 100% match to a 1994 virus (JX256947) from the same study suggesting
possible contamination [51]. The relatively low number of GA7 sequences suggests that this
clade may no longer be circulating or present infrequently enough that it is rarely detected.
RSVB Phylogenetic Analysis
The RSVB genome tree (Fig. 5) includes viruses that had previously been described as belong-
ing to genotypes GB1, GB3, GB4, SAB3, and BA. The full CDS tree (S3 Fig.) also includes virus-
es from genotypes SAB1 and SAB2 while the partial CDS tree (S4 Fig.) includes viruses from
SAB4, GB2 and GB12. Since the RSVB BA genotype emerged in the late 1990s it spread global-
ly and became the predominant genotype [52]. Matching this data, we found the BA clade to
represent the largest proportion of sequences in this study, with 22 of the 23 viruses we se-
quenced belonging to this clade. Many studies have divided members in the BA clade into as
many as 13 different genotypes. However, since different studies use different reference se-
quences for the genotypes and disagree on the total number of genotypes there is much overlap
between genotypes, as evidenced by the partial CDS tree. For example, sequences classified as
belonging to the BA4 genotype are intermixed with those reported as belonging to the BA7,
BA8, BA9, and BA10 genotypes. Despite some fairly distinct clusters of sequences most of the
BA viruses could not readily be divided into separate clades. Only one of the viruses
(KF826853) sequenced in this study belonged to a genotype other than BA (GB3). Viruses in
the GB3/SAB4 clade were identified from 2000 to 2012 in Africa, Asia, Europe, North America,
and South America showing that this clade has continued to circulate globally at low levels
[53]. Viruses have also been identified as recently as 2011 for the GB2 clade [54]. This shows
that even though the viruses that belong to the BA clade have almost completely replaced the
older clades some of the non-BA clades have continued to circulate either in distinct regions or
globally at low levels.
Conclusions
Through this work we have contributed an additional 57 RSVA and RSVB whole virus ge-
nomes to GenBank, significantly increasing the total number of available genomes for RSV. In
addition, these genomes have considerable geographic diversity. By incorporating additional
publically available sequences in our analyses we were able to develop a better understanding
of the evolution and global circulation of RSV viruses. We found that the GA2 and GA5 clades
for RSVA and the BA clade for RSVB have been the predominant RSV clades circulating glob-
ally for at least the past 10 years. Importantly, we did not observe a strong spatial structure in
the tree, with evidence that both main RSVA clades co-circulate globally. These findings sug-
gest that the evolution of RSVA and RSVB is not strongly regionalized, although some small
clades were only identified in one country (e.g., GA7 in the United States). Further surveillance
and sequencing of RSV is required to determine if these minor clades are still circulating in
under sampled regions, as well as to know whether certain RSV lineages dominate over sus-
tained time periods within a defined region, or fluctuate year-to-year. Our phylogenies also in-
dicate that previously used genotype classifications may not be monophyletic, and therefore
highlight the importance of developing improved nomenclature for RSV.
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The majority of RSV sequencing has been focused on RSV evolution and therefore has pri-
marily targeted only a partial region of a single RSV gene. Until recently, this meant that there
were only very few sequences for the conserved regions of RSV, which are critical for the devel-
opment of robust diagnostics. Since viruses continuously evolve, the availability of more whole
virus genome sequences from recent isolates representing the diversity of the circulating RSV
population will aid in the development of reliable diagnostics and monitoring for changes in
areas targeted by current and future RSV therapeutics.
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